查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617875

強度調控放射治療市場：按適應症、放射類型和最終用戶分類 - 2025-2030 年全球預測

Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

強度調控放射治療市場2023年估值為23億美元，預計2024年將達24.3億美元，複合年成長率為5.36%，預計2030年將達33.2億美元。

強度調控放射治療(IMRT) 是一種用於癌症治療的先進放射放射線治療形式，可向惡性或腫瘤內的特定區域提供精確的放射治療，同時最大限度地減少對周圍正常組織的照射。對 IMRT 的需求源於其能夠改善療效和安全性之間的平衡、提高標靶準確性並減少癌症治療中的附帶損害。其應用範圍廣泛，用於多種癌症，包括攝護腺癌、頭頸癌、婦科癌、肺癌、乳癌、胃腸道癌等。最終用途範圍主要包括醫院、癌症研究機構和專業放射治療中心。

主要市場統計
基準年[2023] 23億美元
預測年份 [2024] 24.3億美元
預測年份 [2030] 33.2億美元
複合年成長率（%） 5.36%

根據市場洞察，調強放射治療的成長受到放射治療技術進步、癌症盛行率增加以及對微創治療方案需求不斷成長的顯著影響。最新的潛在機會在於人工智慧和機器學習的整合，以增強治療計劃和即時自適應放射治療技術，質子和重離子治療共用共生創新的潛力。抓住這些機會需要對研發進行投資，並與高科技公司建立策略合作夥伴關係，為下一代放射治療解決方案鋪路。

然而，限制因素包括缺乏有效實施調強放射治療的熟練專業人員，以及設備高成本，限制了其在新興市場的部署。此外，技術創新的快速發展需要持續的培訓和教育，這可能是資源密集的。監管障礙和報銷問題也帶來了挑戰，特別是在衛生基礎設施低度開發的地區。在技​​術創新方面，專注於具有成本效益的治療提供模式、擴大遠端醫療服務以及開發可攜式放射治療系統以實現更廣泛的普及可以提供可行的成長路徑。該市場的特點是高投資需求和快速的技術變革，使其既是充滿活力的創新途徑，也是新參與企業的巨大進入障礙。

市場動態：揭示快速發展的強度調控放射治療市場的關鍵市場洞察

供需的動態交互作用正在改變強度調控放射治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球癌症發生率增加
    • 政府不斷加強癌症控制舉措
    • 全球衛生支出增加
  • 市場限制因素
    • 癌症治療費用上漲
  • 市場機會
    • 強度調控放射治療的持續創新
    • 擴大癌症領域創新療法的採用
  • 市場問題
    • 缺乏熟練的專業人員

波特五力：駕馭調強度調控放射治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解強度調控放射治療市場的外在影響

外部宏觀環境因素在塑造強度調控放射治療市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解強度調控放射治療市場的競爭格局

強度調控放射治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：強度調控放射治療市場供應商的績效評估

FPNV 定位矩陣是評估強度調控放射治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：制定調強度調控放射治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，調強強度調控放射治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球癌症發生率增加
      • 政府加大癌症控制力道
      • 全球醫療費用上漲
    • 抑制因素
      • 癌症治療費用高昂
    • 機會
      • 強度調控放射治療的持續創新
      • 擴大在腫瘤領域引入創新療法
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
    • 適應症：擴大調強放射治療（IMRT）的應用，減少各種適應症的副作用，提升患者的生活品質
    • 放射類型：多用途光子療法首選治療各種腫瘤大小、位置和階段
    • 最終用戶：財力雄厚的醫院擴大採用最新創新技術
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章強度調控放射治療市場：依適應症分類

  • 介紹
  • 乳癌
  • 消化道癌症
  • 婦科癌症
  • 肺癌
  • 攝護腺癌

第7章強度調控放射治療市場：依放射線類型

  • 介紹
  • 碳離子輻射
  • 電子輻射
  • 光子輻射
  • 質子輻射

第8章強度調控放射治療市場：依最終使用者分類

  • 介紹
  • 醫院
  • 獨立放射治療中心

第9章北美及南美強度調控放射治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太強度調控放射治療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲強度調控放射治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • M42 與 QST 簽署協議共用碳離子療法研究
    • IBA 與阿波羅質子癌症中心獨家合作，為全球腫瘤學家提供質子治療培訓
    • 英國首個乳癌質子束治療檢驗開始
  • 戰略分析和建議

公司名單

  • Accuray Incorporated
  • Aetna Inc.
  • Brainlab AG
  • Elekta AB
  • GE Healthcare
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • PMB by ALCEN group
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Xstrahl Group
Product Code: MRR-CF6C60CF95AB

The Intensity Modulated Radiotherapy Market was valued at USD 2.30 billion in 2023, expected to reach USD 2.43 billion in 2024, and is projected to grow at a CAGR of 5.36%, to USD 3.32 billion by 2030.

Intensity Modulated Radiotherapy (IMRT) is an advanced form of radiation therapy used in cancer treatment that focuses on delivering precise radiation doses to a malignant tumor or specific areas within the tumor while minimizing exposure to the surrounding normal tissues. The necessity of IMRT stems from its ability to improve targeting accuracy and reduce collateral damage, enhancing the balance between efficacy and safety in cancer therapeutics. Its application is extensive, being used for various types of cancer, including prostate, head and neck, gynecological, lung, breast, and gastrointestinal cancers. The end-use scope predominantly includes hospitals, cancer research institutes, and specialized radiotherapy centers.

KEY MARKET STATISTICS
Base Year [2023] USD 2.30 billion
Estimated Year [2024] USD 2.43 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 5.36%

Market insights indicate that the growth of IMRT is significantly influenced by technological advancements in radiation therapy, increasing prevalence of cancer, and rising demand for less invasive treatment options. The latest potential opportunities lie in the integration of AI and machine learning to enhance treatment planning and real-time adaptive radiotherapy techniques, alongside possible developments in proton and heavy ion therapy, which share symbiotic technological innovations with IMRT. To seize these opportunities, investments in research and development are essential, along with strategic partnerships with tech companies to pave the way for next-generation radiotherapy solutions.

However, the market faces limitations such as the high cost of equipment, which restricts adoption in developing regions, alongside a scarcity of skilled professionals to effectively implement IMRT procedures. Additionally, the rapid pace of innovation necessitates continuous training and education, which can be resource-intensive. Challenges also include regulatory hurdles and reimbursement issues, particularly in regions with less established healthcare infrastructures. In terms of innovation, focusing on cost-effective treatment delivery models, expanding teletherapy services, and developing portable IMRT systems for broader access could offer viable growth pathways. The market is predominantly characterized by high investment needs and rapid technological transitions, presenting both a vibrant avenue for innovation and substantial entry barriers for new players.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intensity Modulated Radiotherapy Market

The Intensity Modulated Radiotherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of cancer across the world
    • Rise in government initiatives for cancer management
    • Increase in healthcare expenditure globally
  • Market Restraints
    • High cost of cancer treatment
  • Market Opportunities
    • Ongoing innovation in Intensity Modulated Radiotherapy
    • Growing adoption of innovative treatment in the oncology field
  • Market Challenges
    • Shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Intensity Modulated Radiotherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intensity Modulated Radiotherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intensity Modulated Radiotherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intensity Modulated Radiotherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intensity Modulated Radiotherapy Market

A detailed market share analysis in the Intensity Modulated Radiotherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intensity Modulated Radiotherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intensity Modulated Radiotherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intensity Modulated Radiotherapy Market

A strategic analysis of the Intensity Modulated Radiotherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intensity Modulated Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Aetna Inc., Brainlab AG, Elekta AB, GE Healthcare, Hitachi, Ltd., Mevion Medical Systems, PMB by ALCEN group, Siemens Healthineers AG, Varian Medical Systems, Inc., and Xstrahl Group.

Market Segmentation & Coverage

This research report categorizes the Intensity Modulated Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer, Lung Cancer, and Prostate Cancer.
  • Based on Radiation Type, market is studied across Carbon-Ion Radiation, Electron Radiation, Photon Radiation, and Proton Radiation.
  • Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer across the world
      • 5.1.1.2. Rise in government initiatives for cancer management
      • 5.1.1.3. Increase in healthcare expenditure globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in Intensity Modulated Radiotherapy
      • 5.1.3.2. Growing adoption of innovative treatment in the oncology field
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications
    • 5.2.2. Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages
    • 5.2.3. End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intensity Modulated Radiotherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gastrointestinal Cancer
  • 6.4. Gynecological Cancer
  • 6.5. Lung Cancer
  • 6.6. Prostate Cancer

7. Intensity Modulated Radiotherapy Market, by Radiation Type

  • 7.1. Introduction
  • 7.2. Carbon-Ion Radiation
  • 7.3. Electron Radiation
  • 7.4. Photon Radiation
  • 7.5. Proton Radiation

8. Intensity Modulated Radiotherapy Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Radiotherapy Centers

9. Americas Intensity Modulated Radiotherapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intensity Modulated Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intensity Modulated Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. M42 and QST Sign Agreement to Share Research on Carbon Ion Therapy
    • 12.3.2. IBA Partners Exclusively with Apollo Proton Cancer Centre for Providing Proton Beam Therapy Training to Oncologists from Across the Globe
    • 12.3.3. First UK Proton Beam Therapy Trial for Breast Cancer Launches
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Aetna Inc.
  • 3. Brainlab AG
  • 4. Elekta AB
  • 5. GE Healthcare
  • 6. Hitachi, Ltd.
  • 7. Mevion Medical Systems
  • 8. PMB by ALCEN group
  • 9. Siemens Healthineers AG
  • 10. Varian Medical Systems, Inc.
  • 11. Xstrahl Group

LIST OF FIGURES

  • FIGURE 1. INTENSITY MODULATED RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTENSITY MODULATED RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTENSITY MODULATED RADIOTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023